Jeffrey Shuren, director of the FDA's Center for Devices and Radiological Health, and medical device industry representatives responded to questions from Congress about the fifth Medical Device User Fee Amendments (MDUFA), which would set the FDA performance goals and how much it can bring in through fees over the next five years.

Click here to see the full article on the MedTech Dive website.